Formulation and transport properties of tenofovir loaded liposomes through Caco-2 cell model
Authors:
- 5 June 2013
- journal article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 23 (4) , 318-326
Abstract
The aim was to investigate the potential of proliposomes to improve the permeability of tenofovir, anti-HIV, for oral delivery. Tenofovir was incorporated into phosphatidylcholine proliposomes and their absorption was determined in Caco-2 cell cultures grown on Transwell inserts using aqueous drug solutions as reference. Five batches of proliposomes were prepared with different stearylamine levels and characterized in terms of vesicular morphology, drug encapsulation efficiency (EEF), drug leakage, vesicular sizing and surface charges. Cytotoxicity of the reconstituted liposomes was evaluated by the MTT assay. The obtained results showed that increasing the incorporated percentage of stearylamine led to an increase in drug encapsulation, a slower drug leakage and larger liposomes formed. Compared to the drug solutions at corresponding concentrations, the proposed formulations showed a positive relationship (R2 = 0.9756) for the influence of increasing the stearylamine percentage on reduction of mitochondrial activity. Regarding the drug permeability, enhancements of apparent permeability by 16.5- and 5.2-folds were observed for proliposomes formulations with 5% and 15% stearylamine, respectively. A good correlation was observed between the Caco-2 and dialysis models that might indicate passive diffusion as well as paracellular transport as suggested mechanisms for drug absorption. Cationic proliposomes offered a potential formulation to improve the permeation of tenofovir.Keywords
This publication has 35 references indexed in Scilit:
- Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserineJournal of Antimicrobial Chemotherapy, 2007
- Current industrial practices of assessing permeability and P-glycoprotein interactionThe AAPS Journal, 2006
- Caveolae-An Alternative Endocytotic Pathway for Targeted Drug DeliveryCritical Reviews™ in Therapeutic Drug Carrier Systems, 2004
- Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulationJournal of Pharmacy and Pharmacology, 2002
- Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected AdultsAntimicrobial Agents and Chemotherapy, 2001
- Induction of Apoptosis in WEHI 231 Cells by Cationic LiposomesPharmaceutical Research, 2000
- Update on highly active antiretroviral therapy: progress and strategiesBiomedicine & Pharmacotherapy, 2000
- Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein.Journal of Cell Biology, 1996
- Liposomes as a carrier for oral administration of insulin: Effect of formulation factorsJournal of Microencapsulation, 1994
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991